An American startup called Warhound came out of stealth on Thursday with $200 million behind one idea: clone and gene-edit better dogs for the military and police.
The money comes from Sequoia, 8VC and In-Q-Tel, the venture arm tied to U.S. intelligence agencies. The Texas company is run by David Spirk, a former Marine and the Pentagon’s former chief data officer. Ben Lamm of Colossal Biosciences and Anduril founder Palmer Luckey came up with the concept.
The pitch starts with a supply problem. Warhound says more than 80% of the working dogs the U.S. military buys come from Europe, and fewer than half make it through training. Buy 200 today, field about 100 later.
The plan runs in stages: bank cell lines from proven Belgian Malinois and German shepherds, clone the best performers, then edit out variants tied to hip dysplasia, cancer and poor eyesight. Anduril supplies body armor, goggles and sensors that feed data back to handlers.
No dogs exist yet. Lamm expects the first in about two years, and Warhound has no signed customers.
What this means for your dog
Almost nothing in the near term. Pet breeding is not the market Warhound is chasing.
Two pieces are worth watching. The screening that strips out disease variants before a dog is born is the same toolset breeders argue about, so if a puppy seller mentions genetically cleared lines, ask which variants were tested and who ran the test. The other is money: police units have paid more for fewer dogs for years.
The dogs already in service get less attention and have their own health problems, as the Brucella canis diagnoses that killed two UK police dogs showed this month.
Details are in TechCrunch’s report.